(Date:5/9/2008)...lif., May 9 /PRNewswire-USNewsire/ -- U.S.,corpora... help victims of,the Cyclone Nargis in Myanmar are...ef International, to ensure that the aid will reac... "It,s important to remember the complete story of...s with the people and organizations that,provide t...
(Date:5/9/2008).../PRNewswire/ -- Summary: With the recent devastati... deaths and leaving over a,million people homeless...repreneurs Sharon Tucci and Steve Jones have launc...award awareness for humanitarian needs,with hopes...an initial goal,of having 1,000 individuals and co...
(Date:5/9/2008)...ations of Compliance Matters at Defunct Facility, ...th Products Inc.,("Leiner" or "the Company") annou...ent with the United States Department of Justice t...al. The proposed agreement would,resolve the previ...ction,control and distribution of certain over-th...
(Date:5/9/2008)...y 9 /PRNewswire/ -- OxyBand Technologies, Inc. tod...e United States Army to,evaluate the company,s pat...ttlefield and other military wounds. OxyBand Techn... that delivers pure oxygen gas into wounds for,fas...n clinical trials to,accelerate healing and, in la...
Breaking Medicine News(10 mins):Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2Health News:Leiner Health Products Submits Proposed Agreement with Department of Justice to U.S. Bankruptcy Court for Approval 2Health News:OxyBand Technologies Signs Army Contract 2...nts with Bone marrow disorder Myelodysplastic Synd...poetin alfa) for every three weeks found to improv... new drug Aranesp is manufactured by Amgen Biotech...isk MDS patients who were administered with 500 mc...
...Pharmaceutical Company Sanofi Pasteur MSD has prod...ent cervical cancer as it is found to protect infe...ich is responsible for causing cervical cancer. //...il is being conducted by the Pharmaceutical Compan...
...e study recommends that oncology researchers consi...ization with white blood cells as a major reason c...arkable number of traits normally attributed to wh...cluding the ability to migrate to lymph nodes and ...
...e is ready to deal with a nearly certain outbreak ...t 10 years, says a top EU medical expert.// Prof...sease Protection and Control (ECDC) was speaking a...ficers of the 25 EU nations met to discuss protect...
Other Medicine News:Health News:EU medical chief says Europe ready for bird flu 2(Date:5/8/2008)... Efficacy and safety data support potential of as...ophrenia and bipolar I disorder, WASHINGTON, May ...ation,(NYSE: SGP ) today announced that an overvi...rogram was presented at the 161st Annual Meeting o...on, D.C., May 3-8. Data from,the studies, involvin...
(Date:5/8/2008)... Results presented at the 27th Annual Meeting of... (APS), SMYRNA, Ga., May 8 /...stained pain relief from diabetic neuropathic pain...rding to data presented at the,27th annual meeting..., "This is the first placebo-controlled trial of ...
(Date:5/8/2008)... HOUSTON, May 8 /- Go ...on of further clinical trials with Cholesterade (R...nt clinical group of 200,patients in 6 centers aro...edicine Institute at The Methodist Hospital in the... trial. Dr. Bryan was formerly the Team,Physician ...
(Date:5/7/2008)... A new study shows how sounds are amplified i...hearing loss can result from genetic mutation or,o...wire-USNewswire/ -- St. Jude Children,s,Research H...lly powered,amplification mechanism in the cochlea...mans and other mammals. The findings will enable b...
Breaking Medicine Technology:Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4Go Healthy Initiates Additional Clinical Tests on Cholesterade 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 2St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing 3USC study largest of its kind finds older children more likely to develop vision disorders 6428 1USC study largest of its kind finds older children more likely to develop vision disorders 6428 2How IAP antagonist chemicals kill tumors 6425 1How IAP antagonist chemicals kill tumors 6425 2Presentation at ISSN Highlights Soy Protein Advantages for Endurance Athletes 6423 1Presentation at ISSN Highlights Soy Protein Advantages for Endurance Athletes 6423 2Andy Ambrose Joins MassMutuals Institutional Sales Team for Retirement Services 6419 1...rican Association for Cancer Research,(AACR), TORO...,Therapeutics Inc. ("Lorus") today announced prese...RNA compounds at the 98th,Annual Meeting of the AA...rst presentation titled, "Determination of optimiz...el combination,treatment for NSCLC cells in vitro ...
...Apr 17, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZI...l,data strongly supportive of the development of a...nstrates very high,bioavailability when administer...c activity that is particularly well suited to ora... separate posters,today at the American Associatio...
Other Medicine Technology:Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 2Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 3Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 4Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 5ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR 2ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR 3A fixed pipette is ideal for repeated pipetting of a single volume. Fixed volume FInnpipettes offer the same features and advantages as other Finnpipette Digital pipettes: New, streamlined design, S
Inquire
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision.
... Eppendorf Reference Series 2000 Pipette is a syno...pact and robust design, and superior operating com...o operate the measuring stroke and blow-out as wel...pette/tip" system ensures utmost accuracy and prec...
Medicine Products: